Hudson Bay Capital Management LP Pacira Bio Sciences, Inc. Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$36.31 - $46.83 $726,200 - $936,600	-20,000 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$35.66 - $44.99 $713,199 - $899,800	20,000 New	20,000 $761,000
Q2 2018 Aug 13, 2018	SELL	$27.5 - $39.8 $1.68 Million - $2.43 Million	-61,000 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$29.98 - $46.35 $1.83 Million - $2.83 Million	61,000 New	61,000 $1.9 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.